Pharmaniaga Erythromycin Suspension

Pharmaniaga Erythromycin Suspension

Manufacturer:

Pharmaniaga Manufacturing Berhad

Distributor:

Pharmaniaga Logistics
Concise Prescribing Info
Contents
Erythromycin ethylsuccinate
Indications/Uses
Infections due to susceptible organisms.
Dosage/Direction for Use
Adult 1 g daily bd-qds. Severe infections: 2-4 g daily. Childn 30-50 mg/kg daily; doubled in severe infections; 2-8 yr 1 g daily in divided doses; <2 yr 500 mg daily in divided doses.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to macrolides.
Special Precautions
Impaired liver function.
Adverse Reactions
GI disturbances, suprainfections, sensitisation to erythromycin, skin reactions, reversible deafness.
Drug Interactions
Carbamazepine, cyclosporin, theophylline, warfarin, terfenadine, astemizole.
MIMS Class
ATC Classification
J01FA01 - erythromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Presentation/Packing
Form
Pharmaniaga Erythromycin Suspension oral susp 200 mg/5 mL
Packing/Price
60 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in